Several different studies reported hypermethylation of the SFRP4 gene promoter and decreased expression of the SFRP4 protein in tumors of the endometrium, cervix, bladder, pancreas, kidney, esophagus, pituitary gland, and mesothelioma (Pohl et al., 2015). Here, SFRP4 is linked to mesothelioma.